Medclair AB (NGM:MCLR) Cash-to-Debt : 10.89 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medclair AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Medclair AB's cash to debt ratio for the quarter that ended in Mar. 2024 was 10.89.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Medclair AB could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Medclair AB's Cash-to-Debt or its related term are showing as below:

NGM:MCLR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.12 Med: 6.19 Max: No Debt
Current: 10.89

During the past 9 years, Medclair AB's highest Cash to Debt Ratio was No Debt. The lowest was 0.12. And the median was 6.19.

NGM:MCLR's Cash-to-Debt is ranked better than
73.51% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: 1.9 vs NGM:MCLR: 10.89

Medclair AB Cash-to-Debt Historical Data

The historical data trend for Medclair AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Medclair AB Cash-to-Debt Chart

Medclair AB Annual Data

Trend

Apr15

Apr16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.12

0.53

14.69

4.40

8.21

Medclair AB Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															1.67	2.46	2.59	8.21	10.89

Competitive Comparison of Medclair AB's Cash-to-Debt

For the Medical Devices subindustry, Medclair AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medclair AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Medclair AB's Cash-to-Debt falls into.

Medclair AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Medclair AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3.201	/	(0.39	+	0)
	=	8.21

Medclair AB's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.896	/	(0.266	+	0)
	=	10.89

Medclair AB (NGM:MCLR) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Medclair AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Medclair AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medclair AB (NGM:MCLR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Box 3113, Stockholm, SWE, 103 62

Website

https://www.medclair.com

Medclair Invest AB is a research and development company with leading-edge expertise in measurement, collection and destruction of Nitrous Oxide. The customers are found in a number of industries such as Obstetrics, Pediatrics, Emergency departments and Dental Care facilities. The business is operational on a global scale.

Medclair AB (NGM:MCLR) Headlines

No Headlines